Funder
Health Technology Assessment Programme
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Medicine (miscellaneous)
Reference35 articles.
1. WHO. Depression: key facts. 2018; Available from:
http://www.who.int/news-room/fact-sheets/detail/depression
2. Moore M, Yuen HM, Dunn N, Mullee MA, Maskell J, Kendrick T. Explaining the rise in antidepressant prescribing: a descriptive study using the general practice research database. BMJ. 2009;339:b3999 Available from:
http://www.bmj.com/cgi/doi/10.1136/bmj.b3999
.
3. McCrea RL, Sammon CJ, Nazareth I, Petersen I. Initiation and duration of selective serotonin reuptake inhibitor prescribing over time: UK cohort study. Br J Psychiatry. 2016.
4. Tallon D, Wiles N, Campbell J, Chew-Graham C, Dickens C, Macleod U, et al. Mirtazapine added to selective serotonin reuptake inhibitors for treatment-resistant depression in primary care (MIR trial): study protocol for a randomised controlled trial. Trials. 2016;17.
5. NHS Digital. National Statistics Prescription Cost Analysis, England—2016 [Internet]. NHS Digital. 2017.
http://www.hscic.gov.uk/catalogue/PUB17274
. Available from:
http://www.content.digital.nhs.uk/catalogue/PUB23631
Cited by
13 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献